FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved Glenmark's original ANDA for topical betamethasone dipropionate, a generic corticosteroid, for inflammatory skin conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Contact Dermatitis
• Dermatitis
• Psoriasis
• Seborrheic Dermatitis

Drugs mentioned

• Betamethasone dipropionate (topical) (Betamethasone dipropionate)

Snippet

ORIG AP for BETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE)